Cierge Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.00 M
- Revenue Growth -18.19%
- Profit Growth 103.82%
- Ebitda 427.48%
- Net Worth 0.58%
- Total Assets -2.04%
About Cierge Formulations
Cierge Formulations Private Limited (CFPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 January 2014 and has a history of 11 years and one month. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Gautam Mukherjee, Ratna Chakraborty, Gour Mukherjee, and One other member serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900UP2014PTC062001
- Company No.
062001
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2014
- Date of AGM
30 Jun 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Cierge Formulations?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Mukherjee  | Director | 16-Jan-2014 | Current |
| Ratna Chakraborty | Director | 16-Jan-2014 | Current |
| Gour Mukherjee | Director | 16-Jan-2014 | Current |
| Sanjay Mukherjee | Director | 16-Jan-2014 | Current |
Financial Performance of Cierge Formulations.
Cierge Formulations Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 18.19% decrease. The company also saw a substantial improvement in profitability, with a 103.82% increase in profit. The company's net worth moved up by a moderate rise of 0.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cierge Formulations?
In 2018, Cierge Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Allahabad Bank : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2015 | Allahabad Bank | ₹2.00 M | Open |
How Many Employees Work at Cierge Formulations?
Unlock and access historical data on people associated with Cierge Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cierge Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cierge Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.